Skip to main navigation

Search for:

Skip to content

Main Navigation

News & Media
Publications
Join Us
Contact
Blog
Search

About Us
Approach
Platform & Pipeline
Patients & Caregivers
Medical Professionals
Investors

News Releases

Year

December 1, 2023

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read More

November 27, 2023

Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit

Read More

November 9, 2023

Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference

Read More

November 7, 2023

Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update

Read More

November 3, 2023

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read More

November 3, 2023

Vor Bio to Participate in Upcoming Investor Conferences

Read More

November 2, 2023

Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio’s Novel eHSC and CAR-T Platform

Read More

October 3, 2023

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read More

September 25, 2023

Vor Bio to Participate in Upcoming Investor Conferences

Read More

August 30, 2023

Vor Bio to Participate in Upcoming Investor Conferences

Read More

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 21

Shareholder Tools

Print Page

RSS

Email Alerts

Contact IR

Search

Follow us on social media:

Twitter LinkedIn

About Us
Approach
Platform & Pipeline
- Our Platform
- Our Pipeline
Patients & Caregivers
Medical Professionals
- Our Investigational Program
- Clinical Trials
Investors
News & Media
Publications
Join Us
Blog

© 2022 Vor Biopharma

Privacy Policy
Terms of Use